Sanderson Study News Today

13.07.2023 - Originally published by Walgreens Boots AllianceDEERFIELD, IL and SAN FRANCISCO, CA / ACCESSWIRE / July 13, 2023 / Walgreens and Freenome announced a multi-year relationship to advance clinical studies of Freenomes blood-based tests for the early ... Seite 1

Walgreens and Freenome form multi-year relationship to advance clinical studies of Freenome’s blood-based tests for cancer detection.

Recent roundup summary of strategic digital health partnerships from Samsung, Dispatch Health, Walgreens, Humana, Siemens Healthineers...

While CVS Health (CVS) plans to shut down its clinical trials unit, rival pharmacy chain Walgreens Boots Alliance (WBA) continues to expand its business. Read more here.

The pharmacy firm will lend its recruitment technology and infrastructure to enroll a more diverse patient population, beginning with Freenome's Sanderson Study.

The benefits of real-world data (RWD) have been so promising, the FDA now recognizes RWD — and corresponding real-world evidence (RWE) —...

The benefits of real-world data (RWD) have been so promising, the FDA now recognizes RWD — and corresponding real-world evidence (RWE) —...

/PRNewswire/ -- Freenome, a privately held biotech company, announced today that Pennsylvania-based Geisinger is joining as a study partner for the Sanderson...

Freenome, a privately held biotech company, today announced the launch of the Sanderson Study, the company’s latest study of its multiomics platform, in combination with real-world data to detect multiple cancers.

/PRNewswire/ -- With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help journalists...